Tapentadol

Results: 167



#Item
31EXCHANGES_CVSC Template Legacy SP eff[removed]Drug Name Drug Tier Requirements/Limits ADHD/ANTI-NARCOLEPSY/ANTI-OBESITY/ANOREXIANTS

EXCHANGES_CVSC Template Legacy SP eff[removed]Drug Name Drug Tier Requirements/Limits ADHD/ANTI-NARCOLEPSY/ANTI-OBESITY/ANOREXIANTS

Add to Reading List

Source URL: www.caremark.com

Language: English - Date: 2014-08-29 15:22:41
32Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2014-12-02 15:19:13
33Medication Guide NUCYNTA®  ER (new-SINN-tah E-R) (tapentadol) extendedrelease oral tablets, CII When taking NUCYNTA® ER: • Do not change your dose. Take NUCYNTA®  ER exactly as prescribed by your healthcare pro

Medication Guide NUCYNTA®  ER (new-SINN-tah E-R) (tapentadol) extendedrelease oral tablets, CII When taking NUCYNTA® ER: • Do not change your dose. Take NUCYNTA®  ER exactly as prescribed by your healthcare pro

Add to Reading List

Source URL: www.nucynta.com

Language: English - Date: 2014-12-04 09:16:58
341 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-11-18 14:16:12
35Opioids compared to placebo or other treatments for chronic lowback pain[removed]Luis Enrique Chaparro, Andrea D Furlan, Amol Deshpande, Angela MailisGagnon, Steven Atlas5, Dennis C Turk Copyright © 2014

Opioids compared to placebo or other treatments for chronic lowback pain[removed]Luis Enrique Chaparro, Andrea D Furlan, Amol Deshpande, Angela MailisGagnon, Steven Atlas5, Dennis C Turk Copyright © 2014

Add to Reading List

Source URL: www.iwh.on.ca

Language: English - Date: 2015-01-04 22:18:30
36FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting FDA White Oak Campus, Building 31, the Great Room (Rm[removed]White Oa

FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting FDA White Oak Campus, Building 31, the Great Room (Rm[removed]White Oa

Add to Reading List

Source URL: www.fda.gov

Language: English
37DRUG QUANTITY MANAGEMENT POLICY - QUANTITY DURATION Oral Long-Acting Opioids To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: hydrocodone bitartrate extended-release capsules (ZohydroTM ER – Zogenix)

DRUG QUANTITY MANAGEMENT POLICY - QUANTITY DURATION Oral Long-Acting Opioids To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: hydrocodone bitartrate extended-release capsules (ZohydroTM ER – Zogenix)

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-09-23 08:08:07
38Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement

Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement

Add to Reading List

Source URL: www.janssen.com

Language: English - Date: 2014-11-14 09:39:18
391000 HM11260C, a New Generation Long Acting Super GLP-1R Agonist with a unique Pharmacokinetic Profile Improves Glucose Control and GI tolerability; a Phase IIa Clinical Trial in T2DM JaHoon Kang *1) , SooMin Choi 1) ,

1000 HM11260C, a New Generation Long Acting Super GLP-1R Agonist with a unique Pharmacokinetic Profile Improves Glucose Control and GI tolerability; a Phase IIa Clinical Trial in T2DM JaHoon Kang *1) , SooMin Choi 1) ,

Add to Reading List

Source URL: www.hanmipharm.com

Language: English - Date: 2014-03-27 02:03:42
40Comprehensive Pain Management Center In order to make the most of your visit, we require this form be completed to the best of your ability and sent to the Comprehensive Pain Management Center. After completing, please m

Comprehensive Pain Management Center In order to make the most of your visit, we require this form be completed to the best of your ability and sent to the Comprehensive Pain Management Center. After completing, please m

Add to Reading List

Source URL: anmc.org

Language: English - Date: 2014-10-29 17:31:41